Aspire Biopharma Holdings (ASBP) Shares Outstanding (2021 - 2026)

Aspire Biopharma Holdings (ASBP) has reported Shares Outstanding (Entity) for 6 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 16.18% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 16.18% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, up 625.34% from the prior year.
• Shares Outstanding (Entity) was $1.0 million for Q2 2026 at Aspire Biopharma Holdings, up from $156685.0 in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.5 million in Q4 2025 and troughed at $156685.0 in Q1 2026.
• A 5-year average of $745772.9 and a median of $992564.5 in 2025 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 625.34% in 2025 and sank 83.46% in 2026, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $1.1 million in 2022, then tumbled by 77.03% to $247625.0 in 2023, then decreased by 16.77% to $206105.0 in 2024, then jumped by 625.34% to $1.5 million in 2025, then sank by 30.57% to $1.0 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $1.0 million (Q2 2026), $156685.0 (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.